Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Chemoprevention is regarded as one of the most promising and realistic approaches in the prevention of toxic effects of
carcinogenic compounds. In this study, we investigated the chemoprevention efficacy of turmeric for 120 days against a
single dose of (10 mg/rat) 7, 12-dimethylbenz (a) anthracene (DMBA). 60 rats were divided into four groups, 15 for each: Group
I: Control; Group II: Injected with DMBA that induces mammary carcinoma; Group III treated with 5% turmeric before and
after injection with DMBA; Group IV treated with 5% turmeric only as Control 2 and the treatments were administered daily
for 4 months. At the end of experiment, the animals were sacrificed under anesthesia and their sera were used for evaluation
of markers of tumorigenicity (serum levels of Total Sialic Acid (TSA) and carcino-embryonic antigens), markers of endocrine
derangement (serum prolactin and estradiol) and markers of oxidative stress (MDA for lipid peroxidation, nitric oxide and
total antioxidant). The breast tissues were investigated for malignancy. Results showed statistically significant elevation of
Malondialdhyde (MDA), Carcinoembryonic Antigen (CEA), total sialic acid, prolactin, estradiol and nitric oxide and also
statistically significant decrease in body weight and total antioxidant in serum of DMBA treated rats as compared with control
group but administration of turmeric was associated with decreased levels of tumorigenicity, endocrine derangement and
oxidative stress. Histopathological examination revealed the formation of tumor in DMBA-induced rats and these abnormal
changes were ameliorated in the rats supplemented with turmeric. In conclusion, these results suggested that supplementation
of diet with turmeric provided antioxidant defense with chemopreventive activity against DMBA-induced mammary tumors.
Biography
Soha Mohamed Hamdy has completed her PhD in 2001 from Fayoum University. Presently, she is a Professor in Faculty of Science - Chemistry Department at Fayoum University, Egypt.